Most people arrive here having heard about one test: a blood draw that looks for signals from many cancers at once. It is newer than the screening it sits beside, and a signal is a reason for more testing rather than an answer. The same clinics also offer established checks, a mammogram, an at-home stool test, a skin examination, an inherited-risk panel, which have trial evidence behind them and which your own doctor may already be arranging. So the useful question is what each test would change, and who walks you through a result that is not clear.
What these tests are, one at a time
This page is about named tests rather than a screening plan. Clinics group them together because they all concern cancer, and they are not one product: one is a newer blood test still being studied, and the rest are checks that primary care arranges routinely.
Knowing which is which is most of the work. It tells you what a result means, whether you would be buying something twice, and which of them is worth your attention first.
What a multi-cancer blood test measures
A multi-cancer early-detection test reads a blood sample for genetic material shed into the bloodstream by cancer cells, and reports whether it sees a signal. Some versions also predict which part of the body the signal came from. It is a screening test, so it is offered to people with no symptoms.
A signal is not a diagnosis. Confirming one takes imaging and often a biopsy, and locating it can take more than one round. A result showing no signal has not ruled cancer out either, because many cancers shed too little for the test to see. Research networks are running trials now on whether finding cancer this way helps people live longer.
The established checks in the same group
Four of the tests here are ordinary screening, offered at the ages and intervals national expert panels set after reviewing trial evidence: a mammogram, an at-home stool test for colorectal cancer, a skin examination, and a panel reading inherited genes linked to cancer risk. Not every one carries the same weight of evidence, and the skin examination is the clearest example: reviewers have concluded the evidence is insufficient to judge whether examining the skin of adults without symptoms helps or harms them.
The inherited-risk panel is the odd one out for a different reason. It does not look for cancer at all. It reads risk you were born with, which can change which screening you should be having and when it starts.
Before you book, ask what happens after
Every test here has a path that opens when the answer is not clean, and that path is the part clinics tend to describe least. A signal on a blood test, a spot on a skin examination and a positive stool test each lead to a further test that somebody has to arrange.
So ask who reviews an unclear result, how quickly you would hear, who books what comes next, and whether your own doctor receives a copy. Those answers tell you more about what you are buying than the number of cancers a test says it covers.
Finding a cancer before it causes symptoms can mean simpler treatment, which is the reason any of this exists. The trade-off is that testing a well person also turns up signals and spots that come to nothing, and each one can mean more tests, a wait, and real worry first.
How a testing appointment usually goes
Clinics organize this differently, but a first appointment for any of these tests tends to follow the same four steps.
-
A history that decides which test
Family history, previous results and anything you have noticed yourself. This decides which of these is worth doing, and whether an inherited-risk panel belongs first.
-
The sample or the examination
A blood draw, an imaging appointment, a skin check, or a kit posted to you. Ask what is included in what you booked and what would be arranged separately.
-
A result explained by a person
Someone should tell you what was looked for, what was not, and how certain the answer is. Ask who reads yours and whether they specialize in it.
-
What the result commits you to
A clean result means deciding when to repeat. Anything unclear means a defined next test. Ask who arranges it and who receives your records.
What is in this group, how well established it is, and what each test is for
Blood tests that look for signals from many cancers at once, plus the conventional screening you may already be due. These are additions to guideline screening rather than replacements for it, and the clinics offering them generally say so themselves.
Multi-cancer early-detection blood testing is offered under brands like Galleri.
- Multi-cancer early detection blood testemerging
- Screens one blood draw for signals of 50+ cancers. Reads one blood sample for genetic material shed into the bloodstream by cancer cells and reports whether a signal is present, sometimes with a prediction of where it came from. A signal is a starting point rather than an answer: confirming and locating it takes imaging and often a biopsy, and it can take more than one round. No signal does not mean no cancer, and it does not replace the screening you are due by age and risk. Ask before booking who reviews a positive result and who arranges the testing that follows it.
- Mammographyestablished
- Breast cancer screening by X-ray. An x-ray examination of the breast, used to look for cancer before it can be felt. National reviewers recommend it every other year for women aged 40 to 74, so many people are already having it arranged by their own doctor. Where the images are harder to read, often because of dense tissue, the next step is a conversation about additional imaging rather than a diagnosis. If a clinic offers it, ask whether it duplicates something already booked for you.
Tiers are ours, not the clinic’s, and describe the strength of published evidence for the test rather than the quality of any clinic offering it.
How the main options differ
Three kinds of test are sold under this heading. They answer different questions, so lining them up side by side can mislead.
| Approach | What it does | What to know |
|---|---|---|
| A multi-cancer blood test | Reads one blood sample for signals associated with many cancers at once, intended to detect cancers that no single screening test covers. | The newest thing on this page. A signal needs further testing to confirm and to locate, no signal does not rule cancer out, and trials on whether it improves outcomes are still running. |
| Established single-cancer screening | A mammogram, an at-home stool test or a skin examination, each looking closely at one part of the body. | Recommended at particular ages and risk levels, and not all equally: breast and colorectal screening carry a clear recommendation, while reviewers have found the evidence insufficient to judge routine skin examination in people without symptoms. |
| An inherited-risk gene panel | Reads genes linked to inherited cancer risk, to say whether you carry a variant that raises it. | It looks for risk rather than for cancer, and a result can change which screening you should have and when. Results carry information about relatives, so counseling before and after is normally part of it. |
Cancer-detection testing at Long Island clinics
2 of the 12 clinics in our Long Island guide, each with the published services behind the claim.
Common questions
I was offered a multi-cancer blood test. Do I still need the usual screening?
Yes. These tests are offered as an addition to the screening recommended for your age and risk rather than a replacement for it, and the clinics selling them generally say so themselves. The established screens each look closely at one part of the body and have trial evidence behind them, while a multi-cancer test looks broadly and is still being studied. A result showing no signal does not mean you can skip a mammogram or a colonoscopy you are due.
What happens if the blood test finds a signal?
A signal is a reason for further testing rather than a diagnosis. Depending on what the test predicts, the next step is usually imaging, a specialist opinion, and sometimes a biopsy, and it can take more than one round to locate anything or to conclude that nothing is there. That stretch is the hardest part of having the test, so it is fair to ask a clinic before you book who reviews a positive result, how quickly you would hear, and who arranges what comes next.
Is an inherited-risk panel the same thing as a multi-cancer blood test?
No, and they answer opposite questions. A multi-cancer blood test looks for signs that a cancer is present now. An inherited-risk panel reads genes you were born with and says whether you carry a variant that raises your risk of developing certain cancers, which is a fact about you that does not change. A panel result can change which screening you should be having and when it starts, and because it carries information about blood relatives, counseling before and after is normally part of it.
Which of these does my own doctor already arrange?
Often more of them than people expect. Mammography, stool-based colorectal testing and a skin examination are ordinary screening that primary care arranges routinely, and having one again changes nothing except who holds the result, so it is worth checking what is already booked for you before adding a package. If what you want is the wider view of how screening fits together by age and risk rather than a decision about one test, the cancer screening guide for your city covers that ground.
What does this cost, and will insurance cover it?
It varies widely by clinic and by what is included, and some discuss fees only after an initial conversation. Guideline-recommended screening is often covered, with the rules depending on your plan, your age and your risk category. A multi-cancer blood test is commonly self-pay, because coverage generally follows a medical indication rather than a request. Ask what a quoted package includes, and how any follow-up testing would be handled.
How do you decide which clinics appear on this page?
A clinic appears here when its own published material shows it offers cancer-detection testing at that location.
Cancer-detection testing in other cities
Sources
- National Cancer Institute, Questions and answers about multi-cancer detection tests Supports: What a multi-cancer detection blood test measures, and that it reads material shed into the blood; That a signal requires follow-up testing to confirm and to locate, and that a result showing no signal does not rule cancer out; That trials on whether these tests improve outcomes are still under way.
- U.S. Preventive Services Task Force, A and B recommendations Supports: That national expert panels, not individual clinics, set which screens are recommended and at which ages and intervals.
- U.S. Preventive Services Task Force, Breast Cancer: Screening Supports: That screening mammography is recommended every other year for women aged 40 to 74; That where breast tissue is dense the evidence on supplemental imaging is insufficient, so the next step is a discussion rather than a settled answer.
- U.S. Preventive Services Task Force, Colorectal Cancer: Screening Supports: That colorectal cancer screening is recommended from age 45; That stool-based tests are accepted screening options and are repeated on a schedule; That an abnormal stool-based result is followed up with colonoscopy.
- U.S. Preventive Services Task Force, Skin Cancer: Screening Supports: That the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician in adolescents and adults without symptoms.
- National Cancer Institute, Genetic Testing for Inherited Cancer Risk Supports: That a positive inherited-risk result can mean being checked at a younger age or more often; That results carry information about blood relatives; That genetic counseling is generally recommended before testing, and after a positive result; That results can be uninformative, or find a variant of uncertain significance.
- National Cancer Institute, Cancer Screening Overview (PDQ) for patients Supports: That screening is testing done in people who have no symptoms; That screening produces false positives which lead to further tests carrying their own risks.
This page is educational information, not medical advice, and it is not a recommendation to have or to skip any test. Which of these is useful for you depends on your age, your family history and your personal risk, so discuss it with a clinician who knows your history. If you have a symptom that concerns you, seek a medical evaluation rather than a screening test.
Run a longevity practice in Long Island?
Claim your profile to confirm your services, introduce your clinicians and publish your own figures. Claiming is free and never changes the researched facts on this page.
Claim your profile